Financial results - GENŢIANA PHARMA SRL

Financial Summary - Genţiana Pharma Srl
Unique identification code: 25811571
Registration number: J2009000281073
Nace: 4773
Sales - Ron
297.670
Net Profit - Ron
32.938
Employees
5
Open Account
Company Genţiana Pharma Srl with Fiscal Code 25811571 recorded a turnover of 2024 of 297.670, with a net profit of 32.938 and having an average number of employees of 5. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Genţiana Pharma Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 163.363 171.760 174.287 195.496 212.674 255.504 295.552 326.311 299.717 297.670
Total Income - EUR 171.258 177.207 174.288 195.498 212.680 255.514 295.600 326.431 299.732 297.682
Total Expenses - EUR 171.630 174.420 160.595 175.441 194.096 222.497 257.248 280.016 252.024 258.248
Gross Profit/Loss - EUR -372 2.788 13.693 20.057 18.584 33.017 38.353 46.414 47.708 39.434
Net Profit/Loss - EUR -372 2.249 11.879 18.102 16.453 31.115 35.452 43.180 44.699 32.938
Employees 6 6 6 7 6 6 6 6 5 5
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -0.1%, from 299.717 euro in the year 2023, to 297.670 euro in 2024. The Net Profit decreased by -11.512 euro, from 44.699 euro in 2023, to 32.938 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Genţiana Pharma Srl

Rating financiar

Financial Rating -
GENŢIANA PHARMA SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Genţiana Pharma Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Genţiana Pharma Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Genţiana Pharma Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Genţiana Pharma Srl - CUI 25811571

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 14.918 4.801 3.437 2.169 946 607 451 310 166 24
Current Assets 51.367 44.397 48.064 66.237 61.770 102.388 98.576 106.215 115.635 96.874
Inventories 26.286 22.239 22.314 22.457 28.854 41.258 42.186 37.673 49.889 41.148
Receivables 16.691 4.853 17.128 21.057 20.034 30.389 38.001 38.626 40.383 21.929
Cash 8.389 17.305 8.622 22.722 12.881 30.741 18.389 29.916 25.363 33.796
Shareholders Funds -186 2.065 13.909 31.756 16.627 47.427 35.619 43.347 44.867 33.104
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 66.787 47.310 37.883 36.917 46.398 55.809 63.534 63.344 71.196 63.946
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 96.874 euro in 2024 which includes Inventories of 41.148 euro, Receivables of 21.929 euro and cash availability of 33.796 euro.
The company's Equity was valued at 33.104 euro, while total Liabilities amounted to 63.946 euro. Equity decreased by -11.512 euro, from 44.867 euro in 2023, to 33.104 in 2024.

Risk Reports Prices

Reviews - Genţiana Pharma Srl

Comments - Genţiana Pharma Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.